Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial.

Subjects

Subjects :

*HEMATOPOIETIC stem cell transplantation
*IMMUNOLOGICAL adjuvants
*DRUG administration
*MYELOSUPPRESSION
*BLOOD platelets
*CLINICAL trials

Details

Language :

English

ISSN :

10838791

Volume :

21

Issue :

2

Database :

Academic Search Index

Journal :

Biology of Blood & Marrow Transplantation

Publication Type :

Academic Journal

Accession number :

108299745

Full Text :

https://doi.org/10.1016/j.bbmt.2014.11.024